Marshall Wace North America’s Emmaus Life Sciences, Inc. Common Stock EMMA Stock Holding History

Marshall Wace North America’s Portfolio EMMA Stock Details EMMA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q4	–	Sell	-6,008	Closed	-$14K	–	1762
2019 Q3	$14K	Buy	+6,008	New	+$33K	﹤0.01%	1248

Marshall Wace North America's EMMA Position: Q4 2019 in Review

Marshall Wace North America sold out of Emmaus Life Sciences, Inc. Common Stock (EMMA) in Q4 2019, closing a stake of 6,008 shares — an estimated $14K sold.

Marshall Wace North America first reported a position in EMMA in Q3 2019 and held it in 1 quarter. The position peaked at $14K in Q3 2019. 0 funds tracked by Wall St. Rank hold EMMA as of Q4 2019.

Marshall Wace North America reported no remaining Emmaus Life Sciences, Inc. Common Stock position as of Q4 2019 after selling out during the quarter.
Marshall Wace North America sold 6,008 Emmaus Life Sciences, Inc. Common Stock shares in Q4 2019, an estimated $14K.
Marshall Wace North America first reported a position in Emmaus Life Sciences, Inc. Common Stock in Q3 2019 and held it in 1 quarter.
Marshall Wace North America's Emmaus Life Sciences, Inc. Common Stock position peaked at $14K in Q3 2019.
0 funds tracked by Wall St. Rank held Emmaus Life Sciences, Inc. Common Stock as of Q4 2019.

Based on Marshall Wace North America's 13F filing for Q4 2019, filed 14 Feb 2020.